View this PageEdit this PageUploads to this PageHistory of this PageHomeRecent ChangesSearchHelp Guide

Evaluations of Goldberg, Robert M.

This editorial can be used primarily for its treatment of statistical data, which is very extensive, although strictly in support of price regulation. There is an underlying bias here in the use of interviews with executives of the pharmaceutical industry. However, just like the previous source, it does justice to the opposing point of view and gives a very strong and viable argument that profit controls come at the expense of drug development.


Link to this Page